Versant Venture Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,465,384
| Closed | -$30.3M | – | 12 |
|
|
2020
Q4 | $30.3M | Sell |
1,465,384
-750,000
| -34% | -$15.5M | 3.15% | 6 |
|
|
2020
Q3 | $16.9M | Hold |
2,215,384
| – | – | 3.09% | 7 |
|
|
2020
Q2 | $18.5M | Hold |
2,215,384
| – | – | 2.65% | 8 |
|
|
2020
Q1 | $11M | Hold |
2,215,384
| – | – | 3.01% | 6 |
|
|
2019
Q4 | $8.75M | Hold |
2,215,384
| – | – | 2.64% | 4 |
|
|
2019
Q3 | $6.73M | Hold |
2,215,384
| – | – | 2.61% | 5 |
|
|
2019
Q2 | $9.75M | Hold |
2,215,384
| – | – | 2.84% | 5 |
|
|
2019
Q1 | $8.8M | Hold |
2,215,384
| – | – | 2.9% | 5 |
|
|
2018
Q4 | $8.82M | Hold |
2,215,384
| – | – | 4.36% | 4 |
|
|
2018
Q3 | $15.2M | Hold |
2,215,384
| – | – | 5.18% | 4 |
|
|
2018
Q2 | $15M | Hold |
2,215,384
| – | – | 4.67% | 3 |
|
|
2018
Q1 | $14.4M | Hold |
2,215,384
| – | – | 4.61% | 4 |
|
|
2017
Q4 | $9.86M | Hold |
2,215,384
| – | – | 10.37% | 3 |
|
|
2017
Q3 | $13.8M | Hold |
2,215,384
| – | – | 10.54% | 4 |
|
|
2017
Q2 | $20.5M | Hold |
2,215,384
| – | – | 16.15% | 4 |
|
|
2017
Q1 | $20.6M | Hold |
2,215,384
| – | – | 14.95% | 4 |
|
|
2016
Q4 | $18.5M | Hold |
2,215,384
| – | – | 18.05% | 2 |
|
|
2016
Q3 | $15.2M | Hold |
2,215,384
| – | – | 16.97% | 3 |
|
|
2016
Q2 | $11M | Hold |
2,215,384
| – | – | 11.11% | 2 |
|
|
2016
Q1 | $21.4M | Hold |
2,215,384
| – | – | 15.45% | 3 |
|
|
2015
Q4 | $20.8M | Hold |
2,215,384
| – | – | 12.15% | 3 |
|
|
2015
Q3 | $31.1M | Buy |
+2,215,384
| New | +$31.1M | 17.86% | 3 |
|